Extreme blood loss in cancer surgery: is it a verdict to the patient or a challenge to the staff?

Abstract

Background. The development of anesthesiology allows performing combined operations in patients with locally advanced malignant tumors. A logical companion of aggressive cancer surgery is a massive blood loss, which can be so pronounced that it poses a threat to the life of the patient.

Objective. The presented experience is an example of transformation of a nearly fatal situation into a curable one and can be useful in choosing an active treatment strategy in most desperate situations.

Methods. This research includes 25 patients with the blood loss of 20 liters or more during surgery.

Results. The median ratio of infusion to blood loss was 133%, and the ratio of the infusion to all fluid losses amounted to 118%. In 100% of cases, catecholamines were used to support the blood circulation: one drug used in 12% of observations and two to five drugs used in 88% of observations. 2 patients died during the operation. 5 patients died in the early postoperative period from multiple organ failure. The cause of death of another 5 patients was septic complications before the 28th post-op day.

Discussion. Performing operations accompanied by acute massive blood loss requires an effective anesthetic support.

Conclusions. Enforcement of certain diagnostic and therapeutic conditions (stage construction of anesthesia, hemodynamic and laboratory monitoring, adequate venous access, rational infusion, timely use of catecholamines, using «cell-saver» device) in the majority of cases allows completing the operation with the surgical control of hemostasis and successfully enduring traumatic and complicated surgery in half of cases.

Keywords

anesthesiology / cancer surgery / infusion therapy / massive blood loss / postoperative complications

References

[1] Давыдов М.И. Эволюция онкохирургии и ее перспективы / Материалы III съезда онкологов и радиологов стран СНГ; май 25–28, 2004; Минск. — Т.1. — С. 36–42. [Davydov MI. Evolyutsiya onkokhirurgii i ee perspektivy. (Conference proceedings) Materialy III s”ezda onkologov i radiologov stran SNG; 2004 May 25–28; Minsk. Vol.1. Р. 36–42. (In Russ).]

[2] Saif MW, Makrilia N, Zalonis A, et al. Gastric cancer in the elderly: an overview. Eur J Surg Oncol. 2010;36(8):709–717. doi: 10.1016/j.ejso.2010.05.023.

[3] Hasselgren K, Sandström P, Gasslander T, Björnsson B. Multivisceral resection in patients with advanced abdominal tumors. Scand J Surg. 2016;105(3):147–152. doi: 10.1177/1457496915622128.

[4] Пепе А., Мейер Й., Цвисслер Б., Хаблер О. Как вести пациента с массивной интраоперационной кровопотерей. В сб.: Актуальные проблемы анестезиологии и реаниматологии (12-й выпуск) / Под ред. Э.В. Недашковского. — Архангельск, 2007. — С. 82–91. [Pepe A, Meyer Y, Tsvissler B, Khabler O. Kak vesti patsienta s massivnoy intraoperatsionnoy krovopoterey. In: Aktual’nye problemy anesteziologii i reanimatologii (Issue 12). Ed by E.V. Nedashkovskii. Arkhangel›sk; 2007. Рр. 82–91. (In Russ).]

[5] Fredericks Ch, Kubasiak JC, Mentzer CJ, Yon JR. Massive transfusion: an update for the anesthesiologist. World J Anesthesiol. 2017;6(1):14–21. doi: 10.5313/wja.v6.i1.14.

[6] Ghadimi K, Levy JH, Welsby IJ. Perioperative management of the bleeding patient. Br J Anaesth. 2016;117(Suppl 3):18–30. doi: 10.1093/bja/aew358.

[7] Гринхальх Т. Основы доказательной медицины / Пер. с англ. — М.: ГЭОТАР-Медиа, 2018. — 336 с. [Greenhalgh T. How to read a paper: The basics of evidence-based medicine. Translated from English. Moscow: GEOTAR-Media; 2018. 336 р. (In Russ).]

[8] Горобец Е.С., Зотов А.В., Феоктистов П.И. Инфузионно-трансфузионная терапия массивной кровопотери во время хирургического вмешательства. В сб. Анестезиология и интенсивная терапия: 21 взгляд на проблемы XXI века / Под ред. А.М. Овечкина. — М.: Бином, 2011. — С. 11–20. [Gorobets ES, Zotov AV, Feoktistov PI. Infuzionno-transfuzionnaya terapiya massivnoy krovopoteri vo vremya khirurgicheskogo vmeshatel’stva. In: Anesteziologiya i intensivnaya terapiya: 21 vzglyad na problemy XXI veka. Ed by A.M. Ovechkin. Moscow: Binom; 2011. pp. 11–20. (In Russ).]

[9] Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol. 2017;34(6):332–395. doi: 10.1097/EJA.0000000000000630.

[10] McQuilten ZK, Crighton G, Engelbrecht S, et al. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev. 2015;29(2):127–137. doi: 10.1016/j.tmrv.2015.01.001.

[11] Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100. doi: 10.1186/s13054-016-1265-x.

RIGHTS & PERMISSIONS

Feoktistov P.I., Кarmanov I.E.